Astera Labs (ALAB) – Research Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Astera Labs (NASDAQ: ALAB) in the last few weeks:

• 10/3/2025 – Astera Labs is now covered by analysts at Bank of America Corporation. They set a “neutral” rating and a $230.00 price target on the stock.
• 10/3/2025 – Astera Labs was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 10/1/2025 – Astera Labs is now covered by analysts at TD Cowen. They set a “hold” rating and a $200.00 price target on the stock.
• 9/30/2025 – Astera Labs is now covered by analysts at Cowen Inc. They set a “hold” rating on the stock.
• 9/27/2025 – Astera Labs had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 9/17/2025 – Astera Labs had its price target raised by analysts at Citigroup Inc. from $160.00 to $275.00. They now have a “buy” rating on the stock.
• 9/2/2025 – Astera Labs had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $160.00 to $200.00. They now have a “buy” rating on the stock.
• 8/29/2025 – Astera Labs had its price target raised by analysts at Morgan Stanley from $155.00 to $200.00. They now have an “overweight” rating on the stock.
• 8/29/2025 – Astera Labs is now covered by analysts at CICC Research. They set an “outperform” rating and a $190.00 price target on the stock.
• 8/16/2025 – Astera Labs was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 8/12/2025 – Astera Labs was upgraded by analysts at Zacks Research to a “strong-buy” rating.
• 8/7/2025 – Astera Labs had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, up previously from $75.00.
• 8/7/2025 – Astera Labs had its price target raised by analysts at Susquehanna from $80.00 to $125.00. They now have a “neutral” rating on the stock.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 91,441 shares of Astera Labs stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief executive officer owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This trade represents a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jack R. Lazar sold 22,500 shares of the company’s stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the transaction, the director owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,492,036 shares of company stock worth $232,607,552 in the last three months. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.